Researchers discover new 'trick' steroids use to suppress inflammation

January 14, 2015

A new "trick" steroids use to suppress inflammation, which could be used to make new anti-inflammatory drugs without the harmful side effects of steroids, has been discovered by researchers at Georgia State University.

Their findings have been published in the journal Nature Communications.

Glucocorticoids, a class of steroid hormones, are among the most commonly used anti-inflammatory agents. Steroids have been effective at suppressing , but if used for long-term treatment they can cause serious such as increased risk of infections, liver damage, fluid retention, increased blood pressure, weight gain, easy bruising and slower wound healing.

There is an urgent need to develop novel anti-inflammatory strategies to combat inflammation, which is the cause of many human diseases. Inflammation has been linked to cancer, pulmonary diseases, infectious diseases, neurological diseases, arthritis, otitis media (ear infections) and obesity. It is the human body's response to harmful stimuli, such as pathogens or damaged tissues, but an overactive response, too much inflammation, is detrimental and leads to disease. As a result, inflammation must be tightly regulated.

"Chronic inflammatory diseases last for months and years, so you have to have a medicine that can be used for treating inflammation for the long term without having side effects," said Dr. Jian-Dong Li, a lead investigator of the study and director of the Institute for Biomedical Sciences at Georgia State and also a Georgia Research Alliance Eminent Scholar.

It hasn't been fully understood how glucocorticoids control overactive inflammatory response, but this study found a previously unknown, underlying mechanism that steroids use to suppress inflammation. Scientists already knew that steroids suppress inflammation by directly targeting nuclear factor-κB (NF-κB), a master regulator of pro-inflammatory mediators.

"We have found also suppress inflammation by upregulating IRAK-M, a key negative regulator of inflammatory pathways," Li said.

The researchers found glucocorticoids tightly control bacteria-induced innate immune and inflammatory response by enhancing IRAK-M, one of the most critical negative feedback regulators of inflammation that inhibits the activation of the proteins MyD88 and IRAK1/4.

They propose that IRAK-M is a novel target of glucocorticoids to suppress bacteria-induced inflammation. The study provides new insights into the previously unidentified role of glucocorticoids in suppressing inflammation by targeting the central bottleneck proteins MyD88 and IRAK1/4.

This discovery could lead to the development of new therapeutic strategies to control overactive inflammation, Li said.

"We congratulate Dr. Li and his research team on their discovery and for having their findings published in Nature Communications," said C. Michael Cassidy, president and chief executive officer of Georgia Research Alliance. "Scientific breakthroughs stemming from Georgia's research universities are critical components to bringing life-changing therapies to market."

Explore further: Key pathway to stop dangerous, out-of-control inflammation discovered

Related Stories

Key pathway to stop dangerous, out-of-control inflammation discovered

April 9, 2013
A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.

New anti-inflammatory drugs might help avoid side effects of steroids

October 25, 2011
A new class of anti-inflammatory drugs may one day serve as an alternative to steroid medications and possibly help avoid the serious side effects of steroids, based on research findings at the Salk Institute for Biological ...

Alterations in fatty acid synthesis linked to sepsis inflammation

January 9, 2015
Sepsis is a leading cause of death for patients in intensive care units. The excessive systemic inflammation in individuals with sepsis damages organs and can lead to death. Therapeutic options for sepsis are limited and ...

Team finds mechanism of toxin's inflammatory effect on lungs

December 29, 2014
A study released Dec. 23 describes a never-before-seen mechanism by which a bacterial toxin leads to severe inflammation in asthma and other acute and chronic pulmonary diseases. Researchers from The University of Texas Health ...

Protein appears to protect against bone loss in arthritis

September 12, 2014
A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report.

Feijoa and blackberry help reduce inflammation

January 6, 2015
Feijoa and blackberry are two fruits with a strong anti-inflammatory effect that could help people with inflammatory diseases, according to recent research from the University of Auckland.

Recommended for you

Thousands of new microbial communities identified in human body

September 20, 2017
A new study of the human microbiome—the trillions of microbial organisms that live on and within our bodies—has analyzed thousands of new measurements of microbial communities from the gut, skin, mouth, and vaginal microbiome, ...

Study finds immune system is critical to regeneration

September 20, 2017
The answer to regenerative medicine's most compelling question—why some organisms can regenerate major body parts such as hearts and limbs while others, such as humans, cannot—may lie with the body's innate immune system, ...

Immune cells produce wound healing factor, could lead to new IBD treatment

September 20, 2017
Specific immune cells have the ability to produce a healing factor that can promote wound repair in the intestine, a finding that could lead to new, potential therapeutic treatments for inflammatory bowel disease (IBD), according ...

As men's weight rises, sperm health may fall

September 20, 2017
(HealthDay)—A widening waistline may make for shrinking numbers of sperm, new research suggests.

New model may help science overcome the brain's fortress-like barrier

September 19, 2017
Scientists have helped provide a way to better understand how to enable drugs to enter the brain and how cancer cells make it past the blood brain barrier.

Cell-based therapy success could be boosted by new antioxidant

September 19, 2017
Cell therapies being developed to treat a range of conditions could be improved by a chemical compound that aids their survival, research suggests.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

EyeNStein
not rated yet Jan 14, 2015
Excellent. So if they can get a steroid to bind to an inflammation marker cell (like Azithromycin binds to phagocytes) without impeding this newly discovered binding: The effectiveness/side effects ratio could be greatly improved.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.